# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-12-027203
Filing Date
2012-05-09
Accepted
2012-05-09 16:35:51
Documents
7
Period of Report
2012-06-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRELIMINARY PROXY STATEMENT | v312191_pre14a.htm | PRE 14A | 507586
2 | GRAPHIC | logo.jpg | GRAPHIC | 13325
3 | GRAPHIC | sig1.jpg | GRAPHIC | 4223
4 | GRAPHIC | sig2.jpg | GRAPHIC | 4133
5 | GRAPHIC | sig3.jpg | GRAPHIC | 4115
6 | GRAPHIC | proxy01.jpg | GRAPHIC | 139535
7 | GRAPHIC | proxy02.jpg | GRAPHIC | 426747
| Complete submission text file | 0001144204-12-027203.txt |  | 1325387

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33357 | Film No.: 12826240
SIC: 2836 Biological Products, (No Diagnostic Substances)